Summary
Successful exploitation of this vulnerability may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port. BD has determined the affected products are not sold within the United States.
Vulnerabilities 1
-
Unscored —
Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alari…
Revision history
-
#1
ICSMA-18-235-01 BD Alaris Plus
References
-
ICS Advisory ICSMA-18-235-01 Web Version
https://www.cisa.gov/news-events/ics-medical-advisories/icsma-18-235-01
-
Recommended Practices
https://www.cisa.gov/uscert/ics/alerts/ICS-ALERT-10-301-01
-
Recommended Practices
https://www.cisa.gov/uscert/sites/default/files/recommended_practices/NCCIC_ICS-CERT_Defense_in_Depth_2016_S508C.pdf
-
Recommended Practices
https://www.cisa.gov/uscert/ics/tips/ICS-TIP-12-146-01B